Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2016-01-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Different Forms of Creatine
NCT03000582
Physiological Effects of Creatine Supplementation in Active Males
NCT03003988
Effect of Creatine and Caffeine on Muscle Performance
NCT04290819
Creatine Timing on Resistance Training Adaptations in College Athletes
NCT05451498
Impact of OptiCreatine on Plasma Creatine and Gastrointestinal Effects in Males and Females
NCT07225335
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Creatine nitrate, low dose
Creatine nitrate at 3.0 grams (2.0 grams creatine; 1.0 gram nitrate, 3.0 grams dextrose)
Creatine nitrate, low dose
Creatine nitrate at 3.0 grams (2.0 grams creatine, 1.0 gram nitrate, 3.0 grams dextrose)
Creatine nitrate, high dose
Creatine nitrate at 6.0 grams (4.0 grams creatine; 2.0 grams nitrate)
Creatine nitrate, high dose
Creatine nitrate at 6.0 grams (4.0 grams creatine, 2.0 grams nitrate)
Placebo
Placebo at 6.0 grams dextrose
Placebo
Placebo at 6.0 grams (6.0 grams dextrose)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Creatine nitrate, low dose
Creatine nitrate at 3.0 grams (2.0 grams creatine, 1.0 gram nitrate, 3.0 grams dextrose)
Creatine nitrate, high dose
Creatine nitrate at 6.0 grams (4.0 grams creatine, 2.0 grams nitrate)
Placebo
Placebo at 6.0 grams (6.0 grams dextrose)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 6 months immediate prior history of resistance training including bench press and leg press or squat
Exclusion Criteria
* Use of prescription medication (birth control is allowed)
* Pregnant or nursing or plan to become pregnant during the next month
* Creatine or nitrate use in the last eight weeks
* History of smoking
* History of drinking (i.e., 12 drinks per week or more)
* Use of nonsteroidal anti-inflammatory drugs (NSAIDs) including ibuprofen (Advil, Motrin, Nuprin, etc.), indomethacin (Indocin), naproxen (Aleve, Anaprox, Naprelan, Naprosyn), piroxicam (Feldene)
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nutrabolt
INDUSTRY
Texas A&M University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard B Kreider, PhD
Role: PRINCIPAL_INVESTIGATOR
Texas A&M University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB2015-0684
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.